Zensar partnered with the client, a global biotech leader in vaccines and generics, to transition from SAP ECC to SAP S/4HANA using a Bluefield approach on the SAP RISE platform. Leveraging automation tools, the project ensured minimal business disruption, seamless data migration, and third-party integrations while maintaining strict FDA compliance and delivering real-time analytics for enhanced productivity.

Business:
  • SAP ECC mainstream support is ending in 2027
  • Minimizing business disruption
  • Avoiding risks in processes as per FDA norms
  • Change management
     
Technical:
  • Standardization and optimization of business processes
  • Legacy system complexity
  • Data migration and integration